Skyline Ventures

Skyline Ventures

Pulse 2.0

Sutro Biopharma Stock (STRO): Why The Price Substantially Fell

Pulse 2.0

Sutro Biopharma Stock (STRO): Why The Price Substantially Fell Today

Pulse 2.0

Sutro Biopharma Stock (STRO): Why The Price Increased Today

Pulse 2.0 , MedCity News

Why Novo Nordisk (NVO) Is Buying Dicerna Pharmaceuticals (DRNA) For $3.3 Billion

Pulse 2.0

Concert Pharmaceuticals (CNCE) Stock: Why The Price Surged Today

Xconomy , MedCity News

Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug

PE HUB

VC-backed Sutro Biopharma debuts IPO

PE HUB

VC-backed SI-BONE files to go public

$85,400,000 Venture capital (Series E)
PE HUB

Sutro Biopharma snags $85.4 mln Series E

Messaging
FinSMEs

Sutro Biopharma Raises $85.4M in Series E Funding Round

Funding Health
Xconomy

Celgene Narrows Its Relationship With Sutro, No Acquisition Coming

Health
$30,000,000 Post-IPO debt
businesswire , PE HUB

Concert Pharmaceuticals Announces $30 Million Venture Debt Financing from Hercules Capital

$70,000,000 Post-IPO equity
PE HUB

Dicerna scores $70 mln

Funding Stock markets
Xconomy

Proteon Therapeutics Plans Path Forward for Blood Vessel Drug

Health
Xconomy

Genocea Touts Early Look at Placebo-Controlled Herpes Vaccine Study

Health
The Motley Fool

Why It's Been a Wild Few Days for Genocea Biosciences Inc.

Health Stock markets
Xconomy

Genocea Ditches Pneumococcus Vaccine After Phase 2 Flop, Shares Fall

Health
VentureBeat

Avidia Bank Partners with linked2pay to Deliver Avidia Pay

Payments
$26,000,000 Venture capital (Series D)
FinSMEs

Sutro Biopharma Secures $26M in Series D Financing

$48,500,000 Venture capital (Series B)
Added by
via PE Hub

Concert Pharma Raises $48.5 Million